Connect with us

Business

ResMed eyes ‘U-shaped’ recovery after ventilator boom – Sydney Morning Herald

The ventilator maker posted a 24 per cent jump in operating profit but acknowledges demand won’t last.

Published

on

The $40 billion respiratory treatments provider has excited the market with strong quarterly earnings throughout the pandemic as the company fast-tracked production of 150,000 ventilators to meet global demand as COVID-19 took hold.
The business, which has shares listed on the New York and Australian exchanges, revealed on Thursday it had achieved 15 per cent revenue growth for 2020 on a constant currency basis, hitting $US3 billion.
Operating profit was $US243 million for the year, up 24 per …

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending